Login / Signup

Food and Drug Administration's Position on Commonly Injected Biologic Materials in Orthopaedic Surgery: Letter to the Editor.

Andrew S IttlemanShane A Shapiro
Published in: The American journal of sports medicine (2022)
Keyphrases
  • drug administration
  • minimally invasive
  • coronary artery bypass
  • rheumatoid arthritis
  • surgical site infection
  • coronary artery disease
  • acute coronary syndrome
  • climate change